Published in
Elsevier, Clinical Lung Cancer, 2(22), p. 100-109.e3, 2021
DOI: 10.1016/j.cllc.2020.11.001
Links
Tools
Predictive and prognostic potential of TP53 in patients with advanced non-small cell cancer treated with EGFR-TKI: Analysis of a phase III randomized clinical trial (CTONG 0901)
Journal article published in 2020 by
Xiang-Meng Li,
Wen-Feng Li,
Jun-Tao Lin,
Hong Yan,
Hai-Yan Tu,
Hua-Jun Chen,
Bin-Chao Wang,
Zhen Wang,
Qing Zhou,
Xu-Chao Zhang,
Jian Su,
Rui-Lian Chen,
Yi-Long Wu,
Jin-Ji Yang
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 